Analysts think MGRM stock price could increase by 211%
Nov 23, 2024, 12:26 PM
30.96%
What does MGRM do
Monogram Orthopaedics, based in Brooklyn, New York, went public on May 18, 2023, employing 28 staff. The company develops patient-optimized orthopedic implants using 3D printing, AI, and robotics.
3 analysts think MGRM stock price will increase by 210.66%. The current median analyst target is $6.12 compared to a current stock price of $1.97. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
